Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Merrimack pharmaceuticals, inc. symbols : BAX save search
Merrimack Pharmaceuticals Announces Initiation of Phase 1 Clinical Study of MM-398 for Brain Cancer
Published: 2014-11-06 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.685 0.03% 0.03% 110K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
phase 1 cancer brain cancer phase 3 phase 2 train
Merrimack Pharmaceuticals Receives FDA Fast Track Designation for MM-398 in Post-Gemcitabine Metastatic Pancreatic Cancer
Published: 2014-11-19 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.685 0.03% 0.03% 110K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
fda fda fast track fast track cancer pancreatic fast track designation gemcitabine pancreas designation
Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398, Nanoliposomal Irinotecan (nal-IRI), Published in Cancer Research
Published: 2014-12-04 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.685 0.03% 0.03% 110K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
cancer research preclinical pre-clinical
Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium
Published: 2015-01-20 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.685 0.03% 0.03% 110K
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
test cancer gastrointestinal phase 3 symposium
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.